Selling N-Desethyletonitazene NDE Noretonitazene

Selling N-Desethyletonitazene NDE Noretonitazene

Description

Selling N-Desethyletonitazene NDE Noretonitazene

Buy N-Desethyl Etonitazene online.

Buy N-Desethyl Etonitazene onlineN-Desethylisotonitazene (norisotonitazene) is a benzimidazole opioid with potent analgesic effects which has been sold as a designer drug. It was first identified in 2023 as an active metabolite of the closely related compound isotonitazene, and was found to have similar potency. It is one of the strongest benzimidazole opioids discovered, with an analgesic strength 20 times stronger than fentanyl.

Starting in 2023, it has become an increasingly widespread drug of abuse in its own right, linked to numerous overdose cases, and may be considered an analog of the schedule 1 drug metonitazene. In October 2023, the DEA published an intent to temporarily schedule etonitazepipne and N-desethylisotonitazene. As of April 2024, it is not yet controlled in the United States

Technical Information

Buy N-Desethyl Etonitazene online

Formal Name

2-[(4-ethoxyphenyl)methyl]-N-ethyl-5-nitro-1H-benzimidazole-1-ethanamine

CAS Number 2732926-26-8

Molecular Formula C20H24N4O3

Formula Weight 368.4

Purity ≥98%

Formulation(Request formulation change)

A crystalline solid

Solubility(Learn about Variance in Solubility)

  • DMF: 25 mg/ml
  • DMF:PBS (pH 7.2) (1:1): 0.5 mg/ml
  • DMSO: 20 mg/ml
  • Ethanol: 10 mg/ml

λmax

241 nm

SMILES

CCNCCN1C2=CC=C([N+]([O-])=O)C=C2N=C1CC3=CC=C(OCC)C=C3

InChi Code

InChI=1S/C20H24N4O3/c1-3-21-11-12-23-19-10-7-16(24(25)26)14-18(19)22-20(23)13-15-5-8-17(9-6-15)27-4-2/h5-10,14,21H,3-4,11-13H2,1-2H3

InChi Key

RESPFUMJVJRUMB-UHFFFAOYSA-N

Shipping & Storage Information

Storage -20°C

Shipping

Room Temperature in continental US; may vary elsewhere

Stability

≥ 4 years

N-desethyl etonitazene and protonitazepyne: “New” nitazene opioids circulating in Toronto’s unregulated opioid supply

 Buy N-desethyl Etonitazene Cas 2732926-26-8 Isotonitazene cas 14188-81-9 supplier

 

For the first time, Toronto’s Drug Checking Service has identified N-desethyl etonitazene and protonitazepyne in Toronto’s unregulated opioid supply.

N-desethyl etonitazene and protonitazepyne are high-potency synthetic nitazene opioids. N-desethyl etonitazene is considered to be up to 10 times stronger than fentanyl. Protonitazepyne, also known as N-pyrrolidino protonitazene, is considered to be more than 20 times stronger than fentanyl.

N-desethyl etonitazene was first identified by our analysis site member at the Centre for Addiction and Mental Health (Clinical Laboratory and Diagnostic Services) on February 23, 2024. The sample was collected in Toronto’s west end by our collection site member at the Queen West Site of Parkdale Queen West Community Health Centre. The sample was a yellow/beige powder that was expected to be (i.e., got or bought as) fentanyl. The sample did not contain fentanyl – it instead contained N-desethyl etonitazene and caffeine. Toronto’s Drug Checking Service does not currently quantify N-desethyl etonitazene and therefore cannot speak to how much of it was present in the sample. The sample was not reported as being associated with an overdose or other unpleasant or abnormal effects.

Protonitazepyne was first identified by our analysis site member at the Centre for Addiction and Mental Health (Clinical Laboratory and Diagnostic Services) on March 6, 2024, and again the following day on March 7. The samples were collected in Toronto’s west end by our collection site member at the Parkdale Site of Parkdale Queen West Community Health Centre. The samples were blue powders that were expected to be oxycodone (OxyContin). The samples did not contain oxycodone – they instead contained protonitazepyne and etonitazepyne (also known as N-pyrrolidino etonitazene and considered to be more than 20 times stronger than fentanyl). Toronto’s Drug Checking Service does not currently quantify protonitazepyne or etonitazepyne and therefore cannot speak to how much of them were present in the samples. The samples were not reported as being associated with an overdose or other unpleasant or abnormal effects.

What are nitazene opioids?

Nitazene opioids were synthesized in the 1950s to relieve pain but were never clinically approved for market. Most nitazene opioids are considered to be stronger than fentanyl – and therefore classified as “high-potency opioids” by Toronto’s Drug Checking Service. Around 2019, nitazene opioids began presenting in the unregulated drug supply in Europe, the United States, and then Canada. In Canada, nitazene opioids have been especially prevalent in the eastern provinces – primarily Ontario and Quebec.

Toronto’s Drug Checking Service first identified a nitazene opioid in Toronto’s unregulated fentanyl supply in February 2021. Between February 12, 2021, and March 8, 2024, Toronto’s Drug Checking Service:

  • Has identified 10 different nitazene opioids in samples checked, including 4′-hydroxynitazene, 5-aminoisotonitazene, etodesnitazene, etonitazene, etonitazepyne, isotonitazene/protonitazene, metonitazene, N-desethyl etonitazene, N-desethyl isotonitazene, and protonitazepyne. You can learn more about these drugs, including their suspected strength as compared to fentanyl in our Drug Dictionary.
  • Has reported nitazene opioids 555 times in 474 samples. The vast majority of these samples were expected to be fentanyl (418 of 474).
  • Has observed significant variation in the number of expected fentanyl samples that contain nitazene opioids. Between January 1 and March 8, 2024, nitazene opioids were found in 3% of the expected fentanyl samples checked, as compared to 22% between January and March 2022.
  • Has found nitazene opioids in 25 other expected opioid samples, including those expected to be oxycodone (OxyContin) (9 of 474), Percocet (5 of 474), hydromorphone (Dilaudid) (4 of 474), heroin (3 of 474), and hydrocodone (2 of 474). Two samples containing nitazene opioids were expected to be a nitazene opioid.
  • Has not confirmed nitazene opioid contamination in samples that were expected to be other drug types, such as stimulants, psychedelics, dissociatives, or depressants.

What are the potential effects of using N-desethyl etonitazene and protonitazepyne?

  • Since N-desethyl etonitazene and protonitazepyne are so strong, the risk of overdose in increased and greater than normal doses of naloxone may be required to rouse individuals experiencing an overdose.
  • The risk of overdose may be further increased for people who use oxycodone (OxyContin), Percocet, hydromorphone (Dilaudid), or hydrocodone, as compared to people who use fentanyl, because their opioid tolerance may be lower.
  • In expected fentanyl samples, high-potency opioids are often found in combination, likely increasing the strength of the opioids being used and, therefore, increasing the risk of overdose. For example, between January 1 and March 8, 2024, 42% of the expected fentanyl samples checked by Toronto’s Drug Checking Service contained more than one high-potency opioid.
  • In expected fentanyl samples, high-potency opioids are often found in combination with other central nervous system and/or respiratory depressants, such as benzodiazepine-related drugs and veterinary tranquilizers. For example, between January 1 and March 8, 2024, 58% of the expected fentanyl samples checked by Toronto’s Drug Checking Service contained at least one benzodiazepine-related drug and/or veterinary tranquilizer. Using high-potency opioids in combination other central nervous system and/or respiratory depressants increases the risk of dangerous suppression of vitals (e.g., slowing down of breathing, blood pressure, heart rate).

Advice to reduce potential harms associated with using N-desethyl etonitazene and protonitazepyne:

  1. Carry and be trained to use naloxoneN-desethyl etonitazene and protonitazepyne are opioids, meaning naloxone should reverse their effects in an overdose situation. However, since N-desethyl etonitazene and protonitazepyne are so strong, greater than normal doses of naloxone may be required to rouse individuals experiencing an overdose. Oxygen is often also provided in community health settings as a comprehensive overdose response, specifically when benzodiazepine-related drugs and/or veterinary tranquilizers are present, and overdoses are therefore only partially reversed with naloxone.
  2. Get your drugs checkedideally before using, and providing services are available to you.
  3. Use at a supervised consumption site or overdose prevention site – or with someone else and take turns spotting each other.
  4. If you must use alone, let someone know before you use.
  5. Do a small test dose first.
  6. If your drugs did not contain what you were expecting, consider talking to the person you got your drugs from, or get your drugs from another source if possible.

View more general harm reduction tips and help on our website.

Which drug checking technologies can identify N-desethyl etonitazene and protonitazepyne at this time?

  • Our analysis site member at the Centre for Addiction and Mental Health (Clinical Laboratory and Diagnostic Services) has identified N-desethyl etonitazene and protonitazepyne using liquid chromatography-Orbitrap high resolution mass spectrometry (LC-HR-MS).
  • Our analysis site member at St. Michael’s Hospital (Department of Laboratory Medicine) has identified N-desethyl etonitazene and protonitazepyne using gas chromatography-mass spectrometry (GC-MS).
  • Health Canada’s Drug Analysis Service (DAS) has identified protonitazepyne using GC-MS, nuclear magnetic resonance spectroscopy (NMR), and gas chromatography-infrared spectroscopy (GC-IR) in samples submitted by Canadian law enforcement agencies and public health partners. They have not yet identified N-desethyl etonitazene.
  • N-desethyl etonitazene and protonitazepyne are not currently included in the library for the paper spray-mass spectrometer (PS-MS) used by the University of Victoria’s Substance project, however, they are in the process of updating their library.
  • Some Fourier transform infrared spectrometer (FTIR) libraries, such as Kykeon Analytics’, include protonitazepyne. However, it is likely that protonitazepyne would account for less than 5% of the sample, meaning it would fall below the FTIR’s limit of detection and therefore be missed by instrument. To minimize this limitation, FTIR is often coupled with test strips, which are more likely to identify substances in trace amounts. Based on publicly available information, it is unlikely nitazene test strips can identify N-desethyl etonitazene and protonitazepyne.
  • It is unlikely that emerging onsite drug checking technologies can identify N-desethyl etonitazene and protonitazepyne at this time as their libraries are being developed and their limits of detection are being determined.
  • Schedules of Controlled Substances: Temporary Placement of N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene in Schedule I
  • Buy N-Desethyl Etonitazene online
  • Buy N-Desethyl Etonitazene online
  • Buy N-Desethyl Etonitazene online
  • Buy N-Desethyl Etonitazene online
  • Buy N-Desethyl Etonitazene online
  • Buy N-Desethyl Etonitazene online
  • Buy N-Desethyl Etonitazene online
  • Buy N-Desethyl Etonitazene online
  • Buy N-Desethyl Etonitazene online
  • Buy N-Desethyl Etonitazene online
  • Buy N-Desethyl Etonitazene online
  • Buy N-Desethyl Etonitazene online

Schedules of Controlled Substances: Temporary Placement of N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene in Schedule I

Etonitazene

Etonitazene or etodesnitazene (2-{2-[(4-ethoxyphenyl)methyl]− 5-nitro-1H-benzimidazol-1-yl}-N,N-diethylethan-1-amine) was the first compound from the nitazene group encountered on the illicit drug market. In MOR activation assays monitoring either β-arrestin2 or mini-Gi recruitment etonitazene was 22-times (β-arrestin2) and 20-times (mini-Gi) more potent than fentanyl [60].

The presence of etonitazene in a form of a “brownish looking powder” was reported in Italy in the late 1960 s, in Germany in 1987, in Russia in 1998, and in the US in 2003. Etonitazene was not only a potent but also a highly selective MOR ligand (reviewed in [8]). N– and O-deethylation were identified as the predominant metabolism routes of etonitazene, resulting in O-deethylated etazene, N-deethylated etazene and N,O-dideethylated etazene. Less abundant hydroxylated products of the listed above deethylated metabolites were also found

N-desethyl Etonitazene is an opioid analgesic, a derivative of benzimidazole, an active metabolite of atrazine and has a similar molecular structure and has a high opioid activity. This drug atktivno affects the µ-opioid receptors, providing a strong analgesic effect, hypnotic effect. N-desethyl Etonitazene has a potency 60 times or more stronger than morphine. Regular use of N-desethyl Etonitazene can cause opioid addiction, tolerance to the drug develops, with high dosages, side effects such as vomiting, confusion of consciousness, respiratory depression are possible.
This drug is prohibited for import and sale in the United States and some other countries.

This drug is a designer and there is no exact data on its dosages and side effects.

You can buy N-desethyl Etonitazene online at biochemal.com now.

Description:

Synonyms
  • N-desethyl Etonitazene
IUPAC    2-[(4-ethoxyphenyl)methyl]-N-ethyl-5-nitro-1H-benzimidazole-1-ethanamine
Formula    C20H24N4O3
Molecular weight    368.4
CAS    2732926-26-8
Appearance    A crystalline solid, Powder
Purity    ≥ 98 %

Where to Buy Isotonitazene Online: Order Isotonitazene online

Isotonitazene — commonly referred to as “iso ,nitazene , n-desethyl isotonitazene “, like etonitazene, is a benzimidazole-derived opioid analgesic medication that has been sold as a designer drug. In animal studies, it has about half the potency of etonitazene, but it is likely to be less potent in humans, as was the case with etonitazene (1000 times as potent as morphine in animal models yet only 60 times as potent in humans). Buy Isotonitazene online from Rcchemsupply.net

Fentanyl Powder is 100 times more powerful than morphine in humans. As a result, it can’t be twice as strong as etonitazene while also being 60 times as potent as morphine.

Reviews

There are no reviews yet.

Be the first to review “Selling N-Desethyletonitazene NDE Noretonitazene”

Your email address will not be published. Required fields are marked *